Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, Aug. 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate th... Read More

Clinical Trial: The WISE Study (WhatsApp Intervention for Sleep in the Elderly)

U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07751458) titled 'The WISE Study (WhatsApp Intervention for Sleep in the Elderly)' on Dec. 03, 2025. Brief Su... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, Aug. 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy o... Read More

Clinical Trial: Virtual Reality Intervention in Children After Hypospadias Surgery

U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07752680) titled 'Virtual Reality Intervention in Children After Hypospadias Surgery' on July 22. Brief Summa... Read More

Clinical Trial: Graftless Lateral Sinus Lifting Using Peizo Electric Device in Patients With Atrophic Maxilla

U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07753057) titled 'Graftless Lateral Sinus Lifting Using Peizo Electric Device in Patients With Atrophic Maxill... Read More

Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, Aug. 8 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, mu... Read More

Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Singapore, Aug. 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab ... Read More

Couple killed after being run over by train in Gazipur's Sreepur

Bangladesh, Aug. 8 -- A husband and wife have been killed after being run over by a train in Gazipur's Sreepur. The mangled bodies of the couple were recovered from near Izzatpur Railway Station on t... Read More

Clinical Trial: Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations

U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07751783) titled 'Development and Dissemination of Exercise Prescription and Intervention for Cancer Populatio... Read More

Clinical Trial: Comparison of the Effects of Long-Term Rowing Training in Professional Rowers

U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07752927) titled 'Comparison of the Effects of Long-Term Rowing Training in Professional Rowers' on Aug. 02. ... Read More

• ««
• «
• 1579
• 1580
• 1581
• 1582
• 1583
• 1584
• 1585
• 1586
• 1587
• 1588
• »
• »»